๐ŸŽ™๏ธ Episode 6: Statin Intolerant? Say Hello to Bempedoic Acid

20/04/2025 2 min Temporada 1 Episodio 6
๐ŸŽ™๏ธ Episode 6: Statin Intolerant? Say Hello to Bempedoic Acid

Listen "๐ŸŽ™๏ธ Episode 6: Statin Intolerant? Say Hello to Bempedoic Acid"

Episode Synopsis

Send us a text๐Ÿง  Clinical Context:For patients who absolutely cannot tolerate statins โ€” despite trying multiple options or experiencing severe side effects.Reminder: Always try multiple statins first (different types, dosages, timing) before declaring โ€œstatin intolerance.โ€๐Ÿ’Š What is Bempedoic Acid?Non-statin oral agent, works upstream of HMG-CoA reductase.Liver-activated โ€“ avoids muscle toxicity seen in statins.First oral non-statin to reduce MACE-4 endpoints.๐Ÿ“ˆ Clinical Impact:LDL-C reduction: 20โ€“25%.Cardiovascular events:23% โ†“ in MI.19% โ†“ in coronary revascularization.โš ๏ธ Adverse Effects:Gout, gallstones, elevated transaminases.Avoid if history of uric acid disorders.๐Ÿงฉ Clinical Takeaway:Great adjunct to maximally tolerated statin or for rare, true statin-intolerant patients.Not first-line โ€” statins remain king, with 40โ€“50% LDL reduction.

More episodes of the podcast Brilliant Board Review & CME